scispace - formally typeset
Search or ask a question
Author

Edythe D. London

Bio: Edythe D. London is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Nicotinic agonist & Methamphetamine. The author has an hindex of 93, co-authored 482 publications receiving 33741 citations. Previous affiliations of Edythe D. London include Icahn School of Medicine at Mount Sinai & Semel Institute for Neuroscience and Human Behavior.


Papers
More filters
Journal ArticleDOI
TL;DR: It is established that NO mediates the neurotoxicity of glutamate and Hemoglobin, which complexes NO, prevents neurotoxic effects of both N-methyl-D-aspartate and sodium nitroprusside.
Abstract: Nitric oxide (NO) mediates several biological actions, including relaxation of blood vessels, cytotoxicity of activated macrophages, and formation of cGMP by activation of glutamate receptors in cerebellar slices. Nitric oxide synthase (EC 1.14.23.-) immunoreactivity is colocalized with nicotinamide adenine di-nucleotide phosphate diaphorase in neurons that are uniquely resistant to toxic insults. We show that the nitric oxide synthase inhibitors, N omega-nitro-L-arginine (EC50 = 20 microM) and N omega-monomethyl-L-arginine (EC50 = 170 microM), prevent neurotoxicity elicited by N-methyl-D-aspartate and related excitatory amino acids. This effect is competitively reversed by L-arginine. Depletion of the culture medium of arginine by arginase or arginine-free growth medium completely attenuates N-methyl-D-aspartate toxicity. Sodium nitroprusside, which spontaneously releases NO, produces dose-dependent cell death that parallels cGMP formation. Hemoglobin, which complexes NO, prevents neurotoxic effects of both N-methyl-D-aspartate and sodium nitroprusside. These data establish that NO mediates the neurotoxicity of glutamate.

2,229 citations

Journal ArticleDOI
TL;DR: Correlations of metabolic increases in the dorsolateral prefrontal cortex, medial temporal lobe, and cerebellum with self-reports of craving suggest that a distributed neural network, which integrates emotional and cognitive aspects of memory, links environmental cues with cocaine craving.
Abstract: Evidence accumulated over more than 45 years has indicated that environmental stimuli can induce craving for drugs of abuse in individuals who have addictive disorders. However, the brain mechanisms that subserve such craving have not been elucidated. Here a positron emission tomographic study shows increased glucose metabolism in cortical and limbic regions implicated in several forms of memory when human volunteers who abuse cocaine are exposed to drug-related stimuli. Correlations of metabolic increases in the dorsolateral prefrontal cortex, medial temporal lobe (amygdala), and cerebellum with self-reports of craving suggest that a distributed neural network, which integrates emotional and cognitive aspects of memory, links environmental cues with cocaine craving.

900 citations

Journal ArticleDOI
Jeanne E. Savage1, Philip R. Jansen2, Philip R. Jansen1, Sven Stringer1, Kyoko Watanabe1, Julien Bryois3, Christiaan de Leeuw1, Mats Nagel, Swapnil Awasthi4, Peter B. Barr5, Jonathan R. I. Coleman6, Katrina L. Grasby7, Anke R. Hammerschlag1, Jakob Kaminski4, Robert Karlsson3, Eva Krapohl8, Max Lam, Marianne Nygaard9, Chandra A. Reynolds10, Joey W. Trampush11, Hannah Young12, Delilah Zabaneh8, Sara Hägg3, Narelle K. Hansell13, Ida K. Karlsson3, Sten Linnarsson3, Grant W. Montgomery13, Grant W. Montgomery7, Ana B. Muñoz-Manchado3, Erin Burke Quinlan8, Gunter Schumann8, Nathan G. Skene14, Nathan G. Skene3, Bradley T. Webb5, Tonya White2, Dan E. Arking15, Dimitrios Avramopoulos15, Robert M. Bilder16, Panos Bitsios17, Katherine E. Burdick18, Katherine E. Burdick19, Katherine E. Burdick20, Tyrone D. Cannon21, Ornit Chiba-Falek, Andrea Christoforou22, Elizabeth T. Cirulli, Eliza Congdon16, Aiden Corvin23, Gail Davies24, Ian J. Deary24, Pamela DeRosse25, Pamela DeRosse26, Dwight Dickinson27, Srdjan Djurovic28, Srdjan Djurovic29, Gary Donohoe30, Emily Drabant Conley, Johan G. Eriksson31, Thomas Espeseth32, Nelson A. Freimer16, Stella G. Giakoumaki17, Ina Giegling33, Michael Gill23, David C. Glahn21, Ahmad R. Hariri34, Alex Hatzimanolis35, Alex Hatzimanolis36, Matthew C. Keller37, Emma Knowles21, Deborah C. Koltai34, Bettina Konte33, Jari Lahti31, Stephanie Le Hellard28, Todd Lencz25, Todd Lencz26, David C. Liewald24, Edythe D. London16, Astri J. Lundervold28, Anil K. Malhotra25, Anil K. Malhotra26, Ingrid Melle32, Ingrid Melle28, Derek W. Morris30, Anna C. Need38, William Ollier39, Aarno Palotie31, Aarno Palotie19, Aarno Palotie40, Antony Payton39, Neil Pendleton41, Russell A. Poldrack42, Katri Räikkönen31, Ivar Reinvang32, Panos Roussos20, Panos Roussos18, Dan Rujescu33, Fred W. Sabb43, Matthew A. Scult34, Olav B. Smeland32, Nikolaos Smyrnis35, Nikolaos Smyrnis36, John M. Starr24, Vidar M. Steen28, Nikos C. Stefanis35, Nikos C. Stefanis36, Richard E. Straub15, Kjetil Sundet32, Henning Tiemeier2, Aristotle N. Voineskos44, Daniel R. Weinberger15, Elisabeth Widen31, Jin Yu, Gonçalo R. Abecasis45, Ole A. Andreassen32, Gerome Breen6, Lene Christiansen9, Birgit Debrabant9, Danielle M. Dick5, Andreas Heinz4, Jens Hjerling-Leffler3, M. Arfan Ikram46, Kenneth S. Kendler5, Nicholas G. Martin7, Sarah E. Medland7, Nancy L. Pedersen3, Robert Plomin8, Tinca J. C. Polderman1, Stephan Ripke19, Stephan Ripke47, Stephan Ripke4, Sophie van der Sluis, Patrick Sullivan48, Patrick Sullivan3, Scott I. Vrieze12, Margaret J. Wright13, Danielle Posthuma1 
TL;DR: A large-scale genetic association study of intelligence identifies 190 new loci and implicates 939 new genes related to neurogenesis, neuron differentiation and synaptic structure, a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.
Abstract: Intelligence is highly heritable1 and a major determinant of human health and well-being2. Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer's disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.

800 citations

Journal ArticleDOI
01 Jan 1998-Stroke
TL;DR: It is concluded that endogenous estrogen improves stroke outcome during vascular occlusion by exerting both neuroprotective and flow-preserving effects.
Abstract: Background and Purpose —Premenopausal women are at lower risk than men for stroke, but the comparative vulnerability to tissue injury once a cerebrovascular incident occurs is unknown We hypothesized that female rats sustain less brain damage than males during experimental focal ischemia and that the gender difference in ischemic outcome can be eliminated by ovariectomy Methods —Age-matched male (M), intact female (F), and ovariectomized female (O; plasma estradiol: 41±16 pg/mL compared with 74±15 in F and 40±11 in M) rats from two different strains, normotensive Wistar and stroke-prone spontaneously hypertensive rats, were subjected to 2 hours of intraluminal middle cerebral artery occlusion, followed by 22 hours of reperfusion Cerebral blood flow (CBF) was monitored throughout the ischemic period by laser-Doppler flowmetry Infarction volume in the cerebral cortex (Ctx) and caudoputamen (CP) was determined by 2,3,5-triphenyltetrazolium chloride staining In a separate cohort of M, F, and O Wistar rats, absolute rates of regional CBF were measured at the end of the ischemic period by quantitative autoradiography using [14C]iodoantipyrine Results —F rats of either strain had a smaller infarct size in Ctx and CP and a higher laser-Doppler flow during ischemia compared with respective M and O rats Mean end-ischemic CBF was higher in F compared with M and O rats in CP, but not in Ctx Cerebrocortical tissue volume with end-ischemic CBF <10 mL/100 g/min was smaller in F than M rats, but not different from O rats Conclusions —We conclude that endogenous estrogen improves stroke outcome during vascular occlusion by exerting both neuroprotective and flow-preserving effects

694 citations

Journal ArticleDOI
TL;DR: MRI-based maps suggest that chronic methamphetamine abuse causes a selective pattern of cerebral deterioration that contributes to impaired memory performance, and brain substrates may help account for the symptoms of MA abuse, providing therapeutic targets for drug-induced brain injury.
Abstract: We visualize, for the first time, the profile of structural deficits in the human brain associated with chronic methamphetamine (MA) abuse. Studies of human subjects who have used MA chronically have revealed deficits in dopaminergic and serotonergic systems and cerebral metabolic abnormalities. Using magnetic resonance imaging (MRI) and new computational brain-mapping techniques, we determined the pattern of structural brain alterations associated with chronic MA abuse in human subjects and related these deficits to cognitive impairment. We used high-resolution MRI and surface-based computational image analyses to map regional abnormalities in the cortex, hippocampus, white matter, and ventricles in 22 human subjects who used MA and 21 age-matched, healthy controls. Cortical maps revealed severe gray-matter deficits in the cingulate, limbic, and paralimbic cortices of MA abusers (averaging 11.3% below control; p < 0.05). On average, MA abusers had 7.8% smaller hippocampal volumes than control subjects (p < 0.01; left, p = 0.01; right, p < 0.05) and significant white-matter hypertrophy (7.0%; p < 0.01). Hippocampal deficits were mapped and correlated with memory performance on a word-recall test (p < 0.05). MRI-based maps suggest that chronic methamphetamine abuse causes a selective pattern of cerebral deterioration that contributes to impaired memory performance. MA may selectively damage the medial temporal lobe and, consistent with metabolic studies, the cingulate-limbic cortex, inducing neuroadaptation, neuropil reduction, or cell death. Prominent white-matter hypertrophy may result from altered myelination and adaptive glial changes, including gliosis secondary to neuronal damage. These brain substrates may help account for the symptoms of MA abuse, providing therapeutic targets for drug-induced brain injury.

691 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: It is proposed that cognitive control stems from the active maintenance of patterns of activity in the prefrontal cortex that represent goals and the means to achieve them, which provide bias signals to other brain structures whose net effect is to guide the flow of activity along neural pathways that establish the proper mappings between inputs, internal states, and outputs needed to perform a given task.
Abstract: ▪ Abstract The prefrontal cortex has long been suspected to play an important role in cognitive control, in the ability to orchestrate thought and action in accordance with internal goals. Its neural basis, however, has remained a mystery. Here, we propose that cognitive control stems from the active maintenance of patterns of activity in the prefrontal cortex that represent goals and the means to achieve them. They provide bias signals to other brain structures whose net effect is to guide the flow of activity along neural pathways that establish the proper mappings between inputs, internal states, and outputs needed to perform a given task. We review neurophysiological, neurobiological, neuroimaging, and computational studies that support this theory and discuss its implications as well as further issues to be addressed

10,943 citations

Journal ArticleDOI
TL;DR: The discovery that mammalian cells generate nitric oxide, a gas previously considered to be merely an atmospheric pollutant, is providing important information about many biologic processes.
Abstract: The discovery that mammalian cells generate nitric oxide, a gas previously considered to be merely an atmospheric pollutant, is providing important information about many biologic processes. Nitric oxide is synthesized from the amino acid L-arginine by a family of enzymes, the nitric oxide synthases, through a hitherto unrecognized metabolic route -- namely, the L-arginine-nitric oxide pathway1–8. The synthesis of nitric oxide by vascular endothelium is responsible for the vasodilator tone that is essential for the regulation of blood pressure. In the central nervous system nitric oxide is a neurotransmitter that underpins several functions, including the formation of memory. . . .

6,464 citations

Journal ArticleDOI
TL;DR: Current evidence indicates that most of the cytotoxicity attributed to NO is rather due to peroxynitrite, produced from the diffusion-controlled reaction between NO and another free radical, the superoxide anion, which is presented in detail in this review.
Abstract: The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide (NO) has stimulated an extraordinary impetus for scientific research in all the fields of biology and medicine. Since its early description as an endothelial-derived relaxing factor, NO has emerged as a fundamental signaling device regulating virtually every critical cellular function, as well as a potent mediator of cellular damage in a wide range of conditions. Recent evidence indicates that most of the cytotoxicity attributed to NO is rather due to peroxynitrite, produced from the diffusion-controlled reaction between NO and another free radical, the superoxide anion. Peroxynitrite interacts with lipids, DNA, and proteins via direct oxidative reactions or via indirect, radical-mediated mechanisms. These reactions trigger cellular responses ranging from subtle modulations of cell signaling to overwhelming oxidative injury, committing cells to necrosis or apoptosis. In vivo, peroxynitrite generation represents a crucial pathogenic mechanism in conditions such as stroke, myocardial infarction, chronic heart failure, diabetes, circulatory shock, chronic inflammatory diseases, cancer, and neurodegenerative disorders. Hence, novel pharmacological strategies aimed at removing peroxynitrite might represent powerful therapeutic tools in the future. Evidence supporting these novel roles of NO and peroxynitrite is presented in detail in this review.

5,514 citations

Journal ArticleDOI
30 Jul 1982-Science
TL;DR: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed and an attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature.
Abstract: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed. An attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature. Significant cholinergic dysfunctions occur in the aged and demented central nervous system, relationships between these changes and loss of memory exist, similar memory deficits can be artificially induced by blocking cholinergic mechanisms in young subjects, and under certain tightly controlled conditions reliable memory improvements in aged subjects can be achieved after cholinergic stimulation. Conventional attempts to reduce memory impairments in clinical trials hav not been therapeutically successful, however. Possible explanations for these disappointments are given and directions for future laboratory and clinical studies are suggested.

5,318 citations